2025-07-19 - Analysis Report
Okay, here's a comprehensive report on Transmedics Group Inc. (TMDX), incorporating the provided data and analysis.

**Transmedics Group Inc. (TMDX) Analysis**

**0. Executive Summary**

Transmedics Group Inc. (TMDX) is a medical technology company focused on developing and delivering innovative organ preservation systems for transplantation. This report analyzes TMDX's recent performance, financial health, and market indicators.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return:**
    *   TMDX: 227.91%
    *   S&P 500 (VOO): 68.29%
*   **Relative Divergence:**
    *   Current Divergence: 165.7
    *   Relative Divergence: 63.8 (Indicates TMDX is performing strongly relative to its historical divergence range with the S&P 500).

**Analysis:** TMDX has significantly outperformed the S&P 500. The large positive divergence suggests strong recent performance relative to the market. The relative divergence of 63.8 indicates that while TMDX's performance is strong, it is within its historical range of outperformance.

**Alpha, Beta Analysis**

| Year      | CAGR     | MDD   | Alpha   | Beta  | Cap(B) |
| :---------- | :------- | :------ | :------ | :---- | :----- |
| 2019-2021 | -4.0%    | 63.4% | -52.0% | 0.0   | 0.7   |
| 2020-2022 | 140.0%   | 68.3% | 138.0% | 0.1   | 2.1   |
| 2021-2023 | 95.0%    | 69.4% | 77.0% | 0.2   | 2.7   |
| 2022-2024 | 147.0%   | 82.8% | 121.0% | 0.2   | 2.1   |
| 2023-2025 | 109.0%   | 82.8% | 60.0% | 0.5   | 3.7   |

**Analysis:**

*   **CAGR:** Shows very high growth rates in recent periods, indicating strong performance.
*   **MDD:** High Maximum Drawdown (MDD) values indicate significant volatility and risk.
*   **Alpha:** Consistently high positive alpha suggests TMDX significantly outperforms the market on a risk-adjusted basis.
*   **Beta:** Low Beta values (between 0 and 0.5) indicate that TMDX is less volatile than the S&P 500.
*   **Cap(B):** The Market Cap has increased over the years, indicating growth in the company's size.

**2. Recent Stock Price Movement**

*   **Current Price:** $109.88
*   **Previous Close:** $112.52
*   **Change:** -$2.35
*   **5-Day Moving Average:** 113.66
*   **20-Day Moving Average:** 123.88
*   **60-Day Moving Average:** 120.02

**Analysis:** The stock price has decreased recently and is below all three moving averages. This suggests a short-term downward trend.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 23.71 (Oversold)
*   **PPO:** -1.89
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35)
*   **Recent (20-day) Relative Divergence Change:** -2.0 (Negative: Short-term Decline)
*   **Expected Return:** 56.2%

**Analysis:**

*   **MRI:** The low MRI suggests relatively low market risk.
*   **RSI:** An RSI of 23.71 indicates the stock is oversold, potentially signaling a buying opportunity.
*   **PPO:** A negative PPO indicates a bearish trend.
*   **Hybrid Signal:** The hybrid signal suggests a cautious approach, recommending increasing cash holdings.
*   **20-day Relative Divergence Change:** The negative change confirms the recent underperformance relative to the S&P 500.
*   **Expected Return:** The high expected return suggests significant potential for long-term outperformance compared to the S&P 500 if investing at the current price.
*   **Price Change Issue:** The price change of -2.35 shows a recent drop in price, which may reflect the recent news and volatility around TMDX.

**4. Recent News & Significant Events**

*   **[2025-07-15]:**  Major business developments, regulatory changes, or market events.
*   **[2025-07-19]:**  Analyst discussions regarding recent performance and industry/economic outlook.
*   **[2025-07-16]:**  Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-07-18]:**  Market experts highlight both risks and opportunities, advising investors to monitor news and announcements.

**Analysis:** The news indicates TMDX is experiencing significant events that are impacting its stock price. The volatility and the need to monitor news/announcements suggest that external factors and company-specific events are driving the stock's performance.

**5. Recent Earnings Analysis**

| 날짜        | EPS   | 예상 EPS |
| :---------- | :---- | :------- |
| 2025-05-08 | 0.7   | 0.29     |
| 2025-02-27 | 0.19  | 0.22     |
| 2024-10-28 | 0.12  | 0.29     |
| 2024-07-31 | 0.35  | 0.21     |
| 2024-04-30 | 0.35  | 0.03256  |

**Analysis:** TMDX has generally exceeded EPS expectations in recent quarters, indicating solid financial performance. This positive trend in earnings could be a driver of the stock's high growth.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| :----------- | :--------- | :------------ |
| 2025-03-31 | \$0.14B | 61.47%        |
| 2024-12-31 | \$0.12B | 59.21%        |
| 2024-09-30 | \$0.11B | 55.94%        |
| 2024-06-30 | \$0.11B | 60.59%        |
| 2024-03-31 | \$0.10B | 61.91%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
| :----------- | :--------- | :----- |
| 2025-03-31 | \$0.27B | 9.64% |
| 2024-12-31 | \$0.23B | 3.00% |
| 2024-09-30 | \$0.21B | 2.01% |
| 2024-06-30 | \$0.19B | 6.42% |
| 2024-03-31 | \$0.16B | 7.65% |

**Analysis:**

*   **Revenue:** Revenue has been steadily increasing, indicating strong growth in the company's business.
*   **Profit Margin:** High and stable profit margins demonstrate efficient operations and pricing power.
*   **Equity:** The company's equity has increased consistently, suggesting a strong financial position.
*   **ROE:** ROE has fluctuated but generally shows positive returns on equity, indicating effective use of shareholder investments.

**7. Overall Analysis and Conclusion**

Transmedics Group Inc. (TMDX) has demonstrated strong performance, significantly outperforming the S&P 500. The company exhibits high growth potential, as evidenced by increasing revenues, high profit margins, and strong earnings performance.

However, it's important to consider the following:

*   **Volatility:** High MDD values and recent stock volatility suggest higher-than-average risk.
*   **Short-Term Downtrend:** Recent price declines and negative relative divergence indicate short-term weakness.
*   **External Factors:** News events and market discussions are influencing the stock, requiring investors to stay informed.

**Investment Recommendation:**

Given the oversold RSI and high expected return, TMDX may present a buying opportunity for long-term investors. However, the hybrid signal's caution, recent volatility, and negative short-term trends suggest a need for careful consideration and a risk-managed approach. It's recommended to closely monitor news and company announcements before making any investment decisions.
